Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome

Summary

The aim of this randomized placebo-controlled study is to demonstrate the efficiency and safety of the injection of Botulinum Toxin Type A (200 Units) into the external urethral sphincter for the treatment of chronic prostatitis/chronic pelvic pain.

Timeline

Start

2007-04

Primary completion

2013-05

Completion

2013-06

Outcome

Outcome not reported

Stopped (Enrollment): “Slow accrual.”

Drugs

Indications